BMHT Portal | Bongiovi Medical & Health Technologies at ATA 2016

Bongiovi Medical & Health Technologies at ATA 2016

header-doctors02

Bongiovi Health & Medical Technologies is pioneering the use of sound in medicine. Medical Digital Power Station (MDPS) is an FDA listed Class One medical device data system that can significantly improve the intelligibility in telemedicine for both voice communications and auscultation devices. Currently in clinical trials at major U.S. medical institutions, MDPS provides a cost effective solution to many audio related challenges facing the medical community everyday.

Bongiovi Medical will be in attendance at the 2016 American Telemedicine Association conference in Minneapolis on May 14th-17th. Our world-class team of medical professionals and acoustics experts will be represented by:

Daniel Weiss, MD CMO BMHT

Glenn Yeaw, COO of BMHT

Joseph Butera III CTO BMHT

Heath Cohen Telemedicine PM, BMHT

Come visit Bongiovi Medical & Health Technologies at the American Telemedicine Association conference in Minneapolis on May 14-17. We will be located at booth #1314. Participate in “ears-on” demonstrations of our breakthrough technology.

Click here to explore the entire ATA 2016 show in 60 seconds. You don’t want to miss this!

Follow us by clicking on the Facebook and Twitter images below for live updates from #ATA2016

From: BONGIOVI MEDICAL & HEALTH TECHNOLOGIES, LLC AND ITS PARENT COMPANY, BONGIOVI MEDIA & TECHNOLOGY, INC.(COLLECTIVELY, THE "COMPANY"). UPDATES AND INFORMATION HEREIN IS NOT TO BE REPRODUCED OR DISTRIBUTED AND IS INTENDED ONLY FOR THE CONFIDENTIAL USE OF THE SHAREHOLDERS OF THE COMPANY.YOUR REVIEW OF THIS INFORMATION CONSTITUTES YOUR AGREEMENT TO KEEP ALL SUCH INFORMATION CONFIDENTIAL AND NOT TO REPRODUCE, REDISTRIBUTE OR OTHERWISE DISCLOSE ITS CONTENTS TO ANY PERSON OR ENTITY.

The information set out in this update and site is included for information purposes only and is not an offer or an invitation to buy or sell or a solicitation of an offer or invitation to buy or sell or enter into any agreement with respect to any security, product, service or investment. Any opinions expressed do not constitute investment advice and independent advice should be sought where appropriate. All information is current as of the date of publication, subject to change without notice, and may become outdated over time.

Notice — Forward Looking Statements
The updates and information provided herein may contain forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expects", "plans", "anticipates", "believes", "estimates", "predicts", "potential" or "continue" or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. There is no assurance that any forward-looking statements will materialize. You are cautioned not to place undue reliance on forward-looking statements, which reflect expectations only as of this date. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results and we disclaim any intention or obligation to update or revise any forward-looking statements.